Initial treatment, n (%)
| |
Artesunate
|
43 (63)
|
monotherapy
|
39 (57)
|
+ clindamycin
|
2 (3)
|
+ doxycycline
|
2 (3)
|
Quinine
|
19 (28)
|
AP
|
2 (3)
|
AL
|
2 (3)
|
SP + doxycycline
|
1 (2)
|
Unknown oral anti-malarial
|
1 (2)
|
Artesunate
| |
Median number of doses (range)
|
3 (1-7)
|
Median cumulative dose (range), mg
|
600 (120-1320)
|
Median cumulative dose/bodyweight (range), mg/kg
|
7.5 (2.3-18.1)
|
Oral anti-malarial drug after artesunate, n (%)
| |
AP
|
41 (60)
|
AL
|
20 (29)
|
Doxycycline
|
2 (3)
|
Doxycycline + Quinine
|
1 (2)
|
Clindamycin + Quinine
|
1 (2)
|
AP + mefloquine
|
1 (2)
|
Primaquine
|
1 (2)
|
Mefloquine
|
1 (2)
|
Supportive care, n (%)
| |
Erythrocytapheresis
|
4 (6)
|
Exchange transfusion
|
13 (19)
|
Blood transfusion
|
9 (13)
|
Platelets transfusion
|
1 (2)
|
Mechanical ventilation
|
6 (9)
|
Haemodialysis
|
5 (7)
|